|Cat. No. :
|Product Overview :
||Recombinant HSA fusion Interferon alpha-2b produced inP. Pichiais a single, non-glycosylated, polypeptide chain having a molecular mass of 85.7 kDa
||At least 23 different variants of Interferon-alpha are known. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172 amino acids. All IFN-alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN-alpha subtypes differ in their sequences at only one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxyl-terminal end.
||>98% as determined by SDS-PAGE , RP-HPLC and FPLC.
||Lyophilized from a (3mg/ml) solution in containing 2.4mg Tris base and 8.8mg sodium chloride.
|Specific Activity :
||The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 5.0 x 106IU/mg.
||Less than 0.1 ng/µg (IEU/µg) of HSA-IFN-alpha 2b.
||It is recommended to reconstitute the lyophilized HSA-IFN alpha-2b in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.
||Lyophilized HSA-IFN alpha-2b although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution HSA-IFN alpha-2b should be stored at 4°C between 2-7 days and for future use below -18°C. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Aliquot to avoid repeated freeze-thaw cycles.